Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.7075
+0.0575 (8.85%)
Jan 16, 2026, 4:00 PM EST - Market closed
Vaxart Market Cap
Vaxart has a market cap or net worth of $169.79 million as of January 16, 2026. Its market cap has increased by 8.58% in one year.
Market Cap
169.79M
Enterprise Value
158.56M
1-Year Change
8.58%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from $60.35M to $169.79M, an increase of 181.34%. That is a compound annual growth rate of 13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 155.99M | 87.64% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |